Table of Content

1.Executive Summary

  1.1.Global AI in Oncology Market Snapshot, 2024 and 2031

  1.2.Market Opportunity Assessment, 2024 - 2031, US$ Mn

  1.3.Key Market Trends

  1.4.Future Market Projections

  1.5.Premium Market Insights

  1.6.Industry Developments and Key Market Events

  1.7.PMR Analysis and Recommendations

2.Market Overview

  2.1.Market Scope and Definition

  2.2.Market Dynamics

   2.2.1.Drivers

   2.2.2.Restraints

   2.2.3.Opportunity

   2.2.4.Key Trends

  2.3.Macro-Economic Factors

  2.3.1.Global Sectorial Outlook

  2.3.2.Global GDP Growth Outlook

  2.3.3.Global Healthcare Spending Outlook

  2.4.COVID-19 Impact Analysis

  2.5.Forecast Factors - Relevance and Impact

3.Value Added Insights

  3.1.Product Adoption Analysis

  3.2.Technology Assessment

  3.3.Regulatory Landscape

  3.4.Supply Chain Analysis

  3.5.Key Deals and Mergers

  3.6.PESTLE Analysis

  3.7.Porter's Five Force Analysis

4.Price Analysis, 2023A

  4.1.Key Highlights

  4.2.Key Factors Impacting Indication Prices

  4.3.Pricing Analysis, By Component

  4.4.Regional Prices and Indication Preferences

5.Global AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

  5.1.Key Highlights

   5.1.1.Market Size (US$ Mn) and Y-o-Y Growth

   5.1.2.Absolute $ Opportunity

  5.2.Market Size (US$ Mn) Analysis and Forecast

   5.2.1.Historical Market Size (US$ Mn) Analysis, 2018-2022

   5.2.2.Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031

  5.3.Global AI in Oncology Market Outlook: Component

   5.3.1.Introduction / Key Findings

   5.3.2.Historical Market Size (US$ Mn) Analysis, By Component, 2018 - 2022

   5.3.3.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031

    5.3.3.1.Software Solutions

    5.3.3.2.Hardware

    5.3.3.3.Services

  5.4.Market Attractiveness Analysis: Component

  5.5.Global AI in Oncology Market Outlook: Indication

   5.5.1.Introduction / Key Findings

   5.5.2.Historical Market Size (US$ Mn) Analysis, By Indication, 2018 - 2022

   5.5.3.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031

    5.5.3.1.Breast Cancer

    5.5.3.2.Lung Cancer

    5.5.3.3.Prostate Cancer

    5.5.3.4.Colorectal Cancer

    5.5.3.5.Brain Tumour

    5.5.3.6.Others

  5.6.Market Attractiveness Analysis: Indication

  5.7.Global AI in Oncology Market Outlook: Treatment

   5.7.1.Introduction / Key Findings

   5.7.2.Historical Market Size (US$ Mn) Analysis, By Treatment, 2018 - 2022

   5.7.3.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031

    5.7.3.1.Chemotherapy

    5.7.3.2.Immunotherapy

    5.7.3.3.Radiotherapy

    5.7.3.4.Others

  5.8.Market Attractiveness Analysis: Treatment

  5.9.Global AI in Oncology Market Outlook: End User

   5.9.1.Introduction / Key Findings

   5.9.2.Historical Market Size (US$ Mn) Analysis, By End User, 2018 - 2022

   5.9.3.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031

    5.9.3.1.Hospitals

    5.9.3.2.Biopharmaceutical Companies

    5.9.3.3.Academic and Research Centers

    5.9.3.4.Others

  5.10.Market Attractiveness Analysis: End User

6.Global AI in Oncology Market Outlook: Region

  6.1.Key Highlights

  6.2.Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022

  6.3.Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031

   6.3.1.North America

   6.3.2.Europe

   6.3.3.East Asia

   6.3.4.South Asia and Oceania

   6.3.5.Latin America

   6.3.6.Middle East & Africa

  6.4.Market Attractiveness Analysis: Region

7.North America AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

  7.1.Key Highlights

  7.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

   7.2.1.By Country

   7.2.2.By Component

   7.2.3.By Indication

   7.2.4.By Treatment

   7.2.5.By End User

  7.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

   7.3.1.U.S.

   7.3.2.Canada

  7.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031

   7.4.1.Software Solutions

   7.4.2.Hardware

   7.4.3.Services

  7.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031

   7.5.1.Breast Cancer

   7.5.2.Lung Cancer

   7.5.3.Prostate Cancer

   7.5.4.Colorectal Cancer

   7.5.5.Brain Tumour

   7.5.6.Others

  7.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031

   7.6.1.Chemotherapy

   7.6.2.Immunotherapy

   7.6.3.Radiotherapy

   7.6.4.Others

  7.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031

   7.7.1.Hospitals

   7.7.2.Biopharmaceutical Companies

   7.7.3.Academic and Research Centers

   7.7.4.Others

  7.8.Market Attractiveness Analysis

8.Europe AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

  8.1.Key Highlights

  8.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

   8.2.1.By Country

   8.2.2.By Component

   8.2.3.By Indication

   8.2.4.By Treatment

   8.2.5.By End User

  8.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

   8.3.1.Germany

   8.3.2.France

   8.3.3.U.K.

   8.3.4.Italy

   8.3.5.Spain

   8.3.6.Russia

   8.3.7.Türkiye

   8.3.8.Rest of Europe

  8.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031

   8.4.1.Software Solutions

   8.4.2.Hardware

   8.4.3.Services

  8.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031

   8.5.1.Breast Cancer

   8.5.2.Lung Cancer

   8.5.3.Prostate Cancer

   8.5.4.Colorectal Cancer

   8.5.5.Brain Tumour

   8.5.6.Others

  8.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031

   8.6.1.Chemotherapy

   8.6.2.Immunotherapy

   8.6.3.Radiotherapy

   8.6.4.Others

  8.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031

   8.7.1.Hospitals

   8.7.2.Biopharmaceutical Companies

   8.7.3.Academic and Research Centers

   8.7.4.Others

  8.8.Market Attractiveness Analysis

9.East Asia AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

  9.1.Key Highlights

  9.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

   9.2.1.By Country

   9.2.2.By Component

   9.2.3.By Indication

   9.2.4.By Treatment

   9.2.5.By End User

  9.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

   9.3.1.China

   9.3.2.Japan

   9.3.3.South Korea

  9.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031

   9.4.1.Software Solutions

   9.4.2.Hardware

   9.4.3.Services

  9.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031

   9.5.1.Breast Cancer

   9.5.2.Lung Cancer

   9.5.3.Prostate Cancer

   9.5.4.Colorectal Cancer

   9.5.5.Brain Tumour

   9.5.6.Others

  9.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031

   9.6.1.Chemotherapy

   9.6.2.Immunotherapy

   9.6.3.Radiotherapy

   9.6.4.Others

  9.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031

   9.7.1.Hospitals

   9.7.2.Biopharmaceutical Companies

   9.7.3.Academic and Research Centers

   9.7.4.Others

  9.8.Market Attractiveness Analysis

10.South Asia & Oceania AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

  10.1.Key Highlights

  10.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

   10.2.1.By Country

   10.2.2.By Component

   10.2.3.By Indication

   10.2.4.By Treatment

   10.2.5.By End User

  10.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

   10.3.1.India

   10.3.2.Southeast Asia

   10.3.3.ANZ

   10.3.4.Rest of South Asia & Oceania

  10.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031

   10.4.1.Software Solutions

   10.4.2.Hardware

   10.4.3.Services

  10.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031

   10.5.1.Breast Cancer

   10.5.2.Lung Cancer

   10.5.3.Prostate Cancer

   10.5.4.Colorectal Cancer

   10.5.5.Brain Tumour

   10.5.6.Others

  10.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031

   10.6.1.Chemotherapy

   10.6.2.Immunotherapy

   10.6.3.Radiotherapy

   10.6.4.Others

  10.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031

   10.7.1.Hospitals

   10.7.2.Biopharmaceutical Companies

   10.7.3.Academic and Research Centers

   10.7.4.Others

  10.8.Market Attractiveness Analysis

11.Latin America AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

  11.1.Key Highlights

  11.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

   11.2.1.By Country

   11.2.2.By Component

   11.2.3.By Indication

   11.2.4.By Treatment

   11.2.5.By End User

  11.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

   11.3.1.Brazil

   11.3.2.Mexico

   11.3.3.Rest of Latin America

  11.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031

   11.4.1.Software Solutions

   11.4.2.Hardware

   11.4.3.Services

  11.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031

   11.5.1.Breast Cancer

   11.5.2.Lung Cancer

   11.5.3.Prostate Cancer

   11.5.4.Colorectal Cancer

   11.5.5.Brain Tumour

   11.5.6.Others

  11.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031

   11.6.1.Chemotherapy

   11.6.2.Immunotherapy

   11.6.3.Radiotherapy

   11.6.4.Others

  11.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031

   11.7.1.Hospitals

   11.7.2.Biopharmaceutical Companies

   11.7.3.Academic and Research Centers

   11.7.4.Others

  11.8.Market Attractiveness Analysis

12.Middle East & Africa AI in Oncology Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

  12.1.Key Highlights

  12.2.Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

   12.2.1.By Country

   12.2.2.By Component

   12.2.3.By Indication

   12.2.4.By Treatment

   12.2.5.By End User

  12.3.Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

   12.3.1.GCC Countries

   12.3.2.Egypt

   12.3.3.South Africa

   12.3.4.Northern Africa

   12.3.5.Rest of Middle East & Africa

  12.4.Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2023 - 2031

   12.4.1.Software Solutions

   12.4.2.Hardware

   12.4.3.Services

  12.5.Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031

   12.5.1.Breast Cancer

   12.5.2.Lung Cancer

   12.5.3.Prostate Cancer

   12.5.4.Colorectal Cancer

   12.5.5.Brain Tumour

   12.5.6.Others

  12.6.Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2023 - 2031

   12.6.1.Chemotherapy

   12.6.2.Immunotherapy

   12.6.3.Radiotherapy

   12.6.4.Others

  12.7.Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031

   12.7.1.Hospitals

   12.7.2.Biopharmaceutical Companies

   12.7.3.Academic and Research Centers

   12.7.4.Others

  12.8.Market Attractiveness Analysis

13.Competition Landscape

  13.1.Market Share Analysis, 2023

  13.2.Market Structure

   13.2.1.Competition Intensity Mapping By Market

   13.2.2.Competition Dashboard

  13.3.Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

   13.3.1.Azra AI

    13.3.1.1.Overview

    13.3.1.2.Segments and Products

    13.3.1.3.Key Financials

    13.3.1.4.Market Developments

    13.3.1.5.Market Strategy

   13.3.2.IBM

    13.3.2.1 Overview

    13.3.2.2.Segments and Products

    13.3.2.3.Key Financials

    13.3.2.4.Market Developments

    13.3.2.5.Market Strategy

   13.3.3.Siemens Healthcare GmbH

    13.3.3.1.Overview

    13.3.3.2.Segments and Products

    13.3.3.3.Key Financials

    13.3.3.4.Market Developments

    13.3.3.5.Market Strategy

   13.3.4.Intel Corporation

    13.3.4.1.Overview

    13.3.4.2.Segments and Products

    13.3.4.3.Key Financials

    13.3.4.4.Market Developments

    13.3.4.5.Market Strategy

   13.3.5.GE Healthcare

    13.3.5.1.Overview

    13.3.5.2.Segments and Products

    13.3.5.3.Key Financials

    13.3.5.4.Market Developments

    13.3.5.5.Market Strategy

   13.3.6.NVIDIA Corporation

    13.3.6.1.Overview

    13.3.6.2.Segments and Products

    13.3.6.3.Key Financials

    13.3.6.4.Market Developments

    13.3.6.5.Market Strategy

   13.3.7.Digital Diagnostics Inc.

    13.3.7.1.Overview

    13.3.7.2.Segments and Products

    13.3.7.3.Key Financials

    13.3.7.4.Market Developments

    13.3.7.5.Market Strategy

   13.3.8.ConcertAI

    13.3.8.1.Overview

    13.3.8.2.Segments and Products

    13.3.8.3.Key Financials

    13.3.8.4.Market Developments

    13.3.8.5.Market Strategy

   13.3.9.Median Technologies

    13.3.9.1.Overview

    13.3.9.2.Segments and Products

    13.3.9.3.Key Financials

    13.3.9.4.Market Developments

    13.3.9.5.Market Strategy

   13.3.10.PathAI

    13.3.10.1.Overview

    13.3.10.2.Segments and Products

    13.3.10.3.Key Financials

    13.3.10.4.Market Developments

    13.3.10.5.Market Strategy

   13.3.11.Berg (BPGbio Inc.)

    13.3.11.1.Overview

    13.3.11.2.Segments and Products

    13.3.11.3.Key Financials

    13.3.11.4.Market Developments

    13.3.11.5.Market Strategy

   13.3.12.CancerCenter.AI

    13.3.12.1.Overview

    13.3.12.2.Segments and Products

    13.3.12.3.Key Financials

    13.3.12.4.Market Developments

    13.3.12.5.Market Strategy

   13.3.13.iCAD

    13.3.13.1.Overview

    13.3.13.2.Segments and Products

    13.3.13.3.Key Financials

    13.3.13.4.Market Developments

    13.3.13.5.Market Strategy

   13.3.14.JLK Inspection

    13.3.14.1.Overview

    13.3.14.2.Segments and Products

    13.3.14.3.Key Financials

    13.3.14.4.Market Developments

    13.3.14.5.Market Strategy

   13.3.15.Roche Diagnostics

    13.3.15.1.Overview

    13.3.15.2.Segments and Products

    13.3.15.3.Key Financials

    13.3.15.4.Market Developments

    13.3.15.5.Market Strategy

   13.3.16.Zebra Medical Vision

    13.3.16.1.Overview

    13.3.16.2.Segments and Products

    13.3.16.3.Key Financials

    13.3.16.4.Market Developments

    13.3.16.5.Market Strategy

   13.3.17.Illumina Inc.

    13.3.17.1.Overview

    13.3.17.2.Segments and Products

    13.3.17.3.Key Financials

    13.3.17.4.Market Developments

    13.3.17.5.Market Strategy

   13.3.18.Envisionit DeepAI Ltd

    13.3.18.1.Overview

    13.3.18.2.Segments and Products

    13.3.18.3.Key Financials

    13.3.18.4.Market Developments

    13.3.18.5.Market Strategy

14.Appendix

  14.1.Research Methodology

  14.2.Research Assumptions

  14.3.Acronyms and Abbreviations